Skip to main content
Equibles

GEODE CAPITAL MANAGEMENT, LLC

Position in NRSN — NeuroSense Therapeutics Ltd.

CIK 1214717 BOSTON, MA
Back to NRSN Full portfolio

Position in NRSN

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$11,426
-$555 QoQ
Shares Held
15,870
0.0% QoQ
Ownership
0.042%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#7
of 12 holders
Holding Since
Dec 2023
11 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in NRSN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

GEODE CAPITAL MANAGEMENT, LLC holds $22,039,427,018 across 520 Biotechnology names. NRSN ranks #512 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 6,017,848 $2,989,245,636
2 REGN
Regeneron Pharmaceuticals, Inc.
 2,625,810 $1,637,297,566
3 ALNY
Alnylam Pharmaceuticals, Inc.
 2,635,840 $793,466,914
4 RVMD
Revolution Medicines, Inc.
 3,942,676 $738,384,360
5 MRNA
Moderna, Inc.
 9,710,335 $680,014,759
6 INCY
Incyte Corp
 4,750,735 $538,543,319
7 RPRX
Royalty Pharma plc
 8,058,048 $451,814,751
8 INSM
INSMED Inc
 4,220,155 $449,952,925

All Filings in NRSN

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $11,426 15,870
2026-03-31 $11,981 15,870
2025-12-31 $12,204 15,870
2025-09-30 $19,837 15,870
2025-06-30 $29,994 15,870
2025-03-31 $14,759 15,870
2024-12-31 $19,044 15,870
2024-09-30 $15,193 11,963
2024-06-30 $13,398 11,963
2024-03-31 $21,772 11,963
2023-12-31 $9,390 11,963